The latest CRISPR patent fight is on. So is the mudslinging STAT
The filing is the latest development in a high-stakes legal battle that will decide who was the first to make CRISPR genome editing work in eukaryotes.
The latest CRISPR patent fight is on. So is the mudslinging STAT
The filing is the latest development in a high-stakes legal battle that will decide who was the first to make CRISPR genome editing work in eukaryotes.